Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
- Status
- TERMINATED
- Phase
- PHASE3
PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISIS
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
- Status
- COMPLETED
- Phase
- PHASE1
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
MRD-guided Treatment in NPM1mut AML Patients
- Status
- TERMINATED
- Phase
- PHASE2
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Pevonedistat With Azacitidine Versus Azacitidine Alone in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2